Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
43.67
+0.55 (1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Korro Bio Employees
As of December 31, 2023, Korro Bio had 102 total employees, including 101 full-time and 1 part-time employees.
Employees
102
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$860,863
Market Cap
409.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Community Health Systems | 61,000 |
| Organogenesis Holdings | 862 |
| National Research | 435 |
| Arcturus Therapeutics Holdings | 180 |
| KalVista Pharmaceuticals | 150 |
| Monte Rosa Therapeutics | 133 |
| ClearPoint Neuro | 107 |
| Aura Biosciences | 89 |
KRRO News
- 4 weeks ago - Korro to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 5 weeks ago - Korro to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - GlobeNewsWire
- 2 months ago - Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 4 months ago - Korro to Participate in Upcoming September Investor and Scientific Conferences - GlobeNewsWire
- 4 months ago - Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 months ago - Korro to Participate in Upcoming June Investor and Scientific Conferences - GlobeNewsWire